IL139056A0 - Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation - Google Patents
Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferationInfo
- Publication number
- IL139056A0 IL139056A0 IL13905699A IL13905699A IL139056A0 IL 139056 A0 IL139056 A0 IL 139056A0 IL 13905699 A IL13905699 A IL 13905699A IL 13905699 A IL13905699 A IL 13905699A IL 139056 A0 IL139056 A0 IL 139056A0
- Authority
- IL
- Israel
- Prior art keywords
- malignant
- treatment
- cell proliferation
- diseases caused
- pathological cell
- Prior art date
Links
- 230000004663 cell proliferation Effects 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000003211 malignant effect Effects 0.000 title abstract 2
- 230000001575 pathological effect Effects 0.000 title abstract 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 abstract 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19819835 | 1998-05-04 | ||
| DE19838506A DE19838506C2 (de) | 1998-05-04 | 1998-08-25 | Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen |
| PCT/DE1999/001214 WO1999057117A2 (fr) | 1998-05-04 | 1999-04-22 | Derives indoliques et leur utilisation pour le traitement de maladies malignes et autres induites par des proliferations cellulaires pathologiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139056A0 true IL139056A0 (en) | 2001-11-25 |
Family
ID=26045937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13905699A IL139056A0 (en) | 1998-05-04 | 1999-04-22 | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6407102B1 (fr) |
| EP (1) | EP1109785B1 (fr) |
| JP (1) | JP2002514572A (fr) |
| CN (1) | CN1151127C (fr) |
| AT (1) | ATE230394T1 (fr) |
| AU (1) | AU752464B2 (fr) |
| BG (1) | BG104996A (fr) |
| BR (1) | BR9911017A (fr) |
| CA (1) | CA2330756C (fr) |
| CZ (1) | CZ20003960A3 (fr) |
| DE (1) | DE59903921D1 (fr) |
| DK (1) | DK1109785T3 (fr) |
| ES (1) | ES2190221T3 (fr) |
| HU (1) | HUP0102563A3 (fr) |
| IL (1) | IL139056A0 (fr) |
| NO (1) | NO317261B1 (fr) |
| NZ (1) | NZ507735A (fr) |
| PL (1) | PL346840A1 (fr) |
| SK (1) | SK16352000A3 (fr) |
| TR (1) | TR200003206T2 (fr) |
| WO (1) | WO1999057117A2 (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151127C (zh) | 1998-05-04 | 2004-05-26 | Asta药物股份公司 | 吲哚衍生物及其用于治疗恶性肿瘤和其它基于病理细胞增生的疾病的用途 |
| US6719520B2 (en) | 1998-10-08 | 2004-04-13 | Smithkline Beecham Corporation | Method and compounds |
| DE69922526T2 (de) * | 1998-10-08 | 2005-06-02 | Smithkline Beecham Plc, Brentford | 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrol-2,5-dion als glykogen synthase kinase-3 inhibitor (gsk-3) |
| US6713505B2 (en) * | 2000-06-28 | 2004-03-30 | Eli Lilly And Company | spla2 inhibitors |
| CN1466572A (zh) | 2000-07-28 | 2004-01-07 | ס����ҩ��ʽ���� | 吡咯衍生物 |
| TW557298B (en) * | 2000-08-14 | 2003-10-11 | Ciba Sc Holding Ag | A compound, a photopolymerizible composition, a process for producing coatings and a method for causing a photoinitiator to accumulate at the surface of coatings |
| US20030032625A1 (en) * | 2001-03-29 | 2003-02-13 | Topo Target Aps | Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors |
| DE10143079A1 (de) * | 2001-09-03 | 2003-05-15 | Zentaris Ag | Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel |
| US20050267303A1 (en) * | 2001-09-04 | 2005-12-01 | Zentaris Ag | Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals |
| EP1479384A1 (fr) * | 2002-01-30 | 2004-11-24 | Sumitomo Pharmaceuticals Company, Limited | Inhibiteur de fibrose |
| US6800655B2 (en) | 2002-08-20 | 2004-10-05 | Sri International | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| EP1747014A4 (fr) * | 2004-05-03 | 2007-09-12 | Ilypsa Inc | Modulation de la lysophosphatidylcholine et traitement des etats induits par un regime alimentaire |
| CA2627349A1 (fr) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Composes d'azaindole et leur utilisation en tant qu'inhibiteurs de phospholipases a2 |
| US20090306171A1 (en) * | 2005-11-03 | 2009-12-10 | Han-Ting Chang | Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| US7666898B2 (en) * | 2005-11-03 | 2010-02-23 | Ilypsa, Inc. | Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors |
| CA2627353A1 (fr) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Composes d'indole presentant des substituants acides c4 et leur utilisation en tant qu'inhibiteurs de phospholipases a2 |
| AU2006311765A1 (en) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
| US20090142832A1 (en) * | 2007-11-29 | 2009-06-04 | James Dalton | Indoles, Derivatives, and Analogs Thereof and Uses Therefor |
| EP2448938B9 (fr) | 2009-06-29 | 2015-06-10 | Incyte Corporation | Pyrimidinones comme inhibiteurs de pi3k |
| CN101704828A (zh) * | 2009-11-04 | 2010-05-12 | 中国科学院昆明植物研究所 | 山橙素类双吲哚化合物,其药物组合物及其制备方法和用途 |
| TW201130842A (en) * | 2009-12-18 | 2011-09-16 | Incyte Corp | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
| US8759359B2 (en) * | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
| AR081823A1 (es) | 2010-04-14 | 2012-10-24 | Incyte Corp | DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| EP2655374B1 (fr) | 2010-12-20 | 2019-10-23 | Incyte Holdings Corporation | N-(1-(phényl substitué)éthyl)-9h-purin-6-amines en tant qu'inhibiteurs de pi3k |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
| PL3513793T3 (pl) | 2011-09-02 | 2021-09-20 | Incyte Holdings Corporation | Heterocykloaminy jako inhibitory pi3k |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| WO2015191677A1 (fr) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Dérivés d'hétéroarylaminoalkylphényle bicycliques à titre d'inhibiteurs de pi3k |
| RS63963B1 (sr) | 2015-02-27 | 2023-03-31 | Incyte Holdings Corp | Postupak pripreme pi3k inhibitora |
| WO2016183063A1 (fr) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Formes cristallines d'un inhibiteur de pi3k |
| US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| CN106317169B (zh) * | 2015-06-23 | 2019-07-02 | 首都医科大学 | 双吲哚-二肽衍生物,其合成,抗血栓活性和制备抗血栓剂的应用 |
| CN109790191B (zh) * | 2016-08-05 | 2022-04-08 | 香港大学 | 铂配合物及其使用方法 |
| AU2019277560B2 (en) | 2018-06-01 | 2025-04-24 | Incyte Corporation | Dosing regimen for the treatment of PI3K related disorders |
| KR20210142154A (ko) | 2019-03-21 | 2021-11-24 | 옹쎄오 | 암 치료를 위한 키나제 억제제와 조합된 dbait 분자 |
| WO2020245208A1 (fr) | 2019-06-04 | 2020-12-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Utilisation de cd9 en tant que biomarqueur et en tant que biocible dans la glomérulonéphrite ou la glomérulosclérose |
| CN114761006A (zh) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | 对激酶抑制剂产生耐药性的癌症的治疗方法 |
| WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598583A (en) * | 1968-08-09 | 1971-08-10 | Itek Corp | Indomethylene dye bases and their utilization in photographic processes and compositions |
| FR2688220A1 (fr) * | 1992-03-06 | 1993-09-10 | Adir | Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| AU6581094A (en) * | 1993-04-22 | 1994-11-08 | Nippon Shinyaku Co. Ltd. | Benzofurancarboxylic acid derivative and pharmaceutical composition |
| US5656643A (en) | 1993-11-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| ATE456367T1 (de) * | 1993-12-23 | 2010-02-15 | Lilly Co Eli | Proteinkinase c inhibitoren |
| JPH08295688A (ja) * | 1995-04-28 | 1996-11-12 | Sharp Corp | ビスアゾ化合物、その中間体及びそれらの製造方法、並びにビスアゾ化合物を含有する電子写真感光体 |
| DE19547263C2 (de) * | 1995-12-07 | 1999-04-29 | Cardiotec Inc | Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| CN1151127C (zh) | 1998-05-04 | 2004-05-26 | Asta药物股份公司 | 吲哚衍生物及其用于治疗恶性肿瘤和其它基于病理细胞增生的疾病的用途 |
-
1999
- 1999-04-22 CN CNB998058033A patent/CN1151127C/zh not_active Expired - Fee Related
- 1999-04-22 SK SK1635-2000A patent/SK16352000A3/sk unknown
- 1999-04-22 TR TR2000/03206T patent/TR200003206T2/xx unknown
- 1999-04-22 CA CA002330756A patent/CA2330756C/fr not_active Expired - Fee Related
- 1999-04-22 WO PCT/DE1999/001214 patent/WO1999057117A2/fr not_active Ceased
- 1999-04-22 HU HU0102563A patent/HUP0102563A3/hu unknown
- 1999-04-22 BR BR9911017-2A patent/BR9911017A/pt not_active IP Right Cessation
- 1999-04-22 DE DE59903921T patent/DE59903921D1/de not_active Expired - Fee Related
- 1999-04-22 JP JP2000547087A patent/JP2002514572A/ja not_active Withdrawn
- 1999-04-22 AT AT99927711T patent/ATE230394T1/de not_active IP Right Cessation
- 1999-04-22 PL PL99346840A patent/PL346840A1/xx not_active Application Discontinuation
- 1999-04-22 EP EP99927711A patent/EP1109785B1/fr not_active Expired - Lifetime
- 1999-04-22 DK DK99927711T patent/DK1109785T3/da active
- 1999-04-22 AU AU44975/99A patent/AU752464B2/en not_active Ceased
- 1999-04-22 ES ES99927711T patent/ES2190221T3/es not_active Expired - Lifetime
- 1999-04-22 CZ CZ20003960A patent/CZ20003960A3/cs unknown
- 1999-04-22 IL IL13905699A patent/IL139056A0/xx not_active IP Right Cessation
- 1999-05-04 US US09/305,115 patent/US6407102B1/en not_active Expired - Fee Related
-
2000
- 2000-10-24 NZ NZ507735A patent/NZ507735A/xx unknown
- 2000-10-27 NO NO20005448A patent/NO317261B1/no unknown
- 2000-11-28 BG BG104996A patent/BG104996A/xx unknown
-
2002
- 2002-05-03 US US10/137,653 patent/US6812243B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE59903921D1 (de) | 2003-02-06 |
| CN1151127C (zh) | 2004-05-26 |
| ES2190221T3 (es) | 2003-07-16 |
| AU4497599A (en) | 1999-11-23 |
| HK1038354A1 (en) | 2002-03-15 |
| TR200003206T2 (tr) | 2001-07-23 |
| NZ507735A (en) | 2003-04-29 |
| AU752464B2 (en) | 2002-09-19 |
| EP1109785A2 (fr) | 2001-06-27 |
| US6812243B2 (en) | 2004-11-02 |
| EP1109785B1 (fr) | 2003-01-02 |
| PL346840A1 (en) | 2002-02-25 |
| CA2330756A1 (fr) | 1999-11-11 |
| US6407102B1 (en) | 2002-06-18 |
| BR9911017A (pt) | 2001-02-06 |
| JP2002514572A (ja) | 2002-05-21 |
| WO1999057117A3 (fr) | 2001-04-12 |
| NO317261B1 (no) | 2004-09-27 |
| NO20005448D0 (no) | 2000-10-27 |
| CZ20003960A3 (cs) | 2002-04-17 |
| HUP0102563A3 (en) | 2003-04-28 |
| NO20005448L (no) | 2000-10-27 |
| ATE230394T1 (de) | 2003-01-15 |
| HUP0102563A2 (hu) | 2001-11-28 |
| CA2330756C (fr) | 2007-10-02 |
| BG104996A (en) | 2001-07-31 |
| SK16352000A3 (sk) | 2002-07-02 |
| CN1310705A (zh) | 2001-08-29 |
| WO1999057117A2 (fr) | 1999-11-11 |
| DK1109785T3 (da) | 2003-04-22 |
| US20030008898A1 (en) | 2003-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL139056A0 (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| TR200002980T2 (tr) | İnhibe edici etkiye sahip ikame edilmiş indolinonlar | |
| YU61402A (sh) | Pirol substituisani 2 indolinon protein kinazni inhibitori | |
| BR9811956B1 (pt) | naftiridinonas e composição farmacêutica compreendendo as mesmas. | |
| MY127956A (en) | Substituted indolines which inhibit receptor tyrosine kinases | |
| ATE292623T1 (de) | 2-indolinonderivate als modulatoren der proteinkinase-ativität | |
| TR200003514T2 (tr) | Pirol ikame edilmiş 2-indolinon protein kinaz inhibitörleri | |
| PL324285A1 (en) | Pyrollepyrimidines and methods of obtaining them | |
| AP2000001996A0 (en) | Heterocyclic inhibitors of P38. | |
| TR199900048T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler | |
| MY117696A (en) | INHIBITORS OF p38 | |
| NZ506329A (en) | Inhibitors of phospholipase enzymes | |
| BG104938A (bg) | Заместени индолинони, тяхното получаване и тяхното приложение като лекарствени средства | |
| SI1070056T1 (en) | Phthalazinone pde iii/iv inhibitors | |
| MXPA04006271A (es) | Derivados de indolinona utiles como inhibidores de la proteina cinasa. | |
| DE69723863D1 (de) | Chinoline und deren therapeutische verwendung | |
| DE60023025D1 (de) | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren | |
| WO2001027080A3 (fr) | Indolinones substituees en position 5, leur production et leur utilisation comme medicament | |
| EA200301005A1 (ru) | Замещенные в положении 6 индолиноны и их применение в качестве ингибиторов киназ | |
| ATE243698T1 (de) | 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate | |
| BG105549A (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
| IL169334A0 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors | |
| TR200100476T2 (tr) | N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HP | Change in proprietorship | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |